Next Article in Journal
Comparison of Kinetics of Antibody Avidity and IgG Subclasses’ Response in Patients with COVID-19 and Healthy Individuals Vaccinated with the BNT162B2 (Comirnaty, Pfizer/BioNTech) mRNA Vaccine
Next Article in Special Issue
Correction: Yu et al. Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments. Viruses 2022, 14, 1938
Previous Article in Journal
Nationwide Laboratory Surveillance of Progressive Multifocal Leukoencephalopathy in Japan: Fiscal Years 2011–2020
Previous Article in Special Issue
Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting
 
 
Review

Article Versions Notes

Viruses 2023, 15(4), 967; https://doi.org/10.3390/v15040967
Action Date Notes Link
article xml file uploaded 14 April 2023 16:09 CEST Original file -
article xml uploaded. 14 April 2023 16:09 CEST Update https://www.mdpi.com/1999-4915/15/4/967/xml
article pdf uploaded. 14 April 2023 16:09 CEST Version of Record https://www.mdpi.com/1999-4915/15/4/967/pdf
article supplementary file uploaded. 14 April 2023 16:09 CEST - https://www.mdpi.com/1999-4915/15/4/967#supplementary
article html file updated 14 April 2023 16:11 CEST Original file https://www.mdpi.com/1999-4915/15/4/967/html
Back to TopTop